Amendment 2 SW COVID-19 Testing.pdf

AMENDMENT #2

DATE: JUNE 8, 2021

STATE OF MARYLAND

DEPARTMENT OF GENERAL SERVICES

OFFICE OF STATE PROCUREMENT

ITB NUMBER: 001IT821246 / BPM024037

STATEWIDE – COVID-19 TESTING PRODUCTS

This Amendment is issued to clarify, add to, delete from, correct and/or change the BID documents to the extent indicated and is hereby made a part of the said BID documents on which the contract will be based. This Amendment becomes part of the bid package. COMAR

21.05.02.08 requires all Amendments issued to be acknowledged.

Issued by:

State of Maryland Department of General Services Office of Procurement and Logistics 301 W. Preston Street, Room M-4 Baltimore, Maryland 21201

Charles W. Bailey Charles W. Bailey, CPPB, CMPO DGS Procurement Officer

Acknowledgment Signature Date

AMENDMENT #2

ITB NUMBER: 001IT821246 / BPM024037

STATEWIDE – COVID-19 TESTING PRODUCTS

Amend IFB Section Ab1 and 3 as follows:

1) A Contract shall be awarded to the responsible Bidder(s) in each Functional Area submitting a responsive Bid with the most favorable bid price or most favorable evaluated bid price (as referenced in COMAR 21.05.02.13) for providing the goods and services as specified in this IFB. Bidders must bid all line items for each Functional Area. Bidders may bid on one, two or three both Functional Areas. Partial or incomplete bids will be rejected unless otherwise stated in the solicitation. See IFB Section 6 for Bid evaluation and award information.

3) One award will be made in each functional area to the lowest Bidder in the respective functional area. Up to nine additional awards will be made to the next lowest Bidder(s) providing different test products in each functional area for a total of up to 10 awards in each functional area for 10 different test products. For multiple contract awards, the Contractor with the lowest Bid price in each functional area will be given the right of first refusal to provide the requested products. If that Contractor is unwilling or unable to provide the requested products, the Contractor with the next lowest Bid price will be asked to provide the requested products, and so forth. Each Contractor will have one Business Day to respond to a product request before a request is made to the next subsequent Contractor. For the purposes of the Contracts resulting from this solicitation, a Contractor will be deemed to have “refused” the product request if for a particular request its offered products do not meet the specificity, sensitivity, or test administration considerations, or exceeds the Contractor’s stated or known product availability or stated or known delivery timeframe or capabilities, needed for that request. If “refused” in such cases, the product request will be offered to the next lowest-priced Contractor that meets the product request needs.

Amend IFB Section C1 as follows:

1) The Department intends to make up to 10 awards in eachboth of the threetwo functional areas for the work under this IFB. See IFB Section B, Item B – Basis of Award for more Contract award information.

Amend IFB Section C3b) to add as follows:

b) It is the State's intention to make up to 10 awards in each of two functional areas based on COVID- 19 test type. Functional Area 1 will be for Polymerase Chain Reaction (PCR) or Molecular Amplification Diagnostic COVID-19 tests, that are EUA-issued, packaged, and sold for at-home use where the collected sample(s) are mailed to a lab or the test provides results at home (“at-home PCR test”). Functional Area 2 will be for Rapid Point-of-Care (Antigen Diagnostic) COVID-19 tests. Bidders may bid on one or both functional areas. Functional Area 3 will be for COVID-19 serology tests that can be collected at home and sent to a lab for resulting. Bidders may bid on one, two or threeboth functional areas.

Amend IFB Section C3b) as follows:

b) The Department intends to make up to 10 awards in both of the threetwo functional areas for the work under this IFB. See IFB Section AB, Item B – Basis of Award for more Contract award information.

Amend IFB Section C6b)1) as follows:

1) Is an at-home PCR or rapid point-of-care (POC) COVID-19 test meet the description of test types found in Table 1 (below) for Functional Areas 1 and 2, respectively; or a EUA-serology test that meets the criteria specified in this IFB Section C6b.

Amend IFB Section C6b)3) as follows:

3) All PCR tests used under the Contract must meet the following standards: Sensitivity ≥ 90% and Specificity ≥ 95%. All POC rapid antigen tests used under the Contract must meet the following standards: Sensitivity ≥ 84% and Specificity ≥ 95%. All serology tests must meet the following standards: ≥ 97.5% and Specificity ≥ 99.3%.Show a combined sensitivity of greater than 90% and a specificity greater than 95%;

Amend IFB Section C6b)4) as follows:

4) Produce results in 30 minutes or less for rapid PCR or POC antigen diagnostic tests and 48 hours or less for standardat-home PCR and serology tests;

Amend IFB Section C6b) Table 1 as follows:

Table 1: Description of Test Types for FA 1 and FA2

Amend the Bid form, as shown in the Pricing tab, “Amendment 2 COVID 19 Test Products FA 1 FA2 and FA 3.”

Attachment S

2. BIDDERS SHALL HAVE AT LEAST THREE (3) YEARS EXPERIENCE IN PROVIDING

SIMILAR TYPE WORK AS SPECIFIED IN THIS IFB.

END OF AMENDMENT #2

Attachments:

1. Pre-Bid Conference Minutes and Q&A

2. Pre-Bid Conference Information to Bidders Slides

3. Pre-Bid Attendance Sheet